Navigation Links
Neogen Forms Mexican Subsidiary
Date:6/10/2008

LANSING, Mich., June 10 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today the formation of its new subsidiary in Mexico, Neogen Latino America SPA. The new company, headquartered in Mexico City, will distribute the company's food and animal safety products throughout Mexico.

Neogen Latino America unifies Neogen's widespread business activities throughout Mexico to animal and crop producers, and food processors. The new company will also work with the United States and Mexico on programs to ensure the safety of food products that move across the border from either country. As a result of nearly 20 years of use, Neogen products have earned the trust of Mexican producers of meat and milk, and food processors.

"Much as we did earlier with the acquisition of our Scottish and German food safety distributors, we now see an opportunity to greatly strengthen our presence in Mexico," said Lon Bohannon, Neogen's president. "We believe Mexico continues to hold unrealized opportunities for sales growth."

Approximately $40 million of Neogen's FY 2008 revenue came from international sources.

Neogen's new company will start business with a revenue base of over $2 million (U.S.) that came from multiple sources in FY 2008. Jose Noriega, the former president of Biotecnologia Industrial, will manage the new company and own a minority interest.

"We are pleased to have Jose head the new company and direct our expansion," said Bohannon. "We have enjoyed a close relationship with him for 20 years as a distributor of Neogen's food safety products."

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
2. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
3. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
4. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
5. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
6. Neogen Launches Quickest Test Available for Tetracyclines in Milk
7. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
8. Neogen Acquires Assets of Rivard Instruments
9. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
10. Neogen Acquires Kane Enterprises
11. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... San Diego, CA (PRWEB) , ... May 26, ... ... assay development and manufacturing company, today announced several positive developments that position the ... As a result of the transaction, Craig F. Kinghorn has been appointed ...
(Date:5/25/2016)... ... May 25, 2016 , ... Founder of the Fitzmaurice Hand ... and surgery of the hand by the National Board of Physicians and Surgeons, ... and beyond in his pursuit of providing the most comprehensive, effective treatment for ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company ... granted the company’s orphan drug designation request covering BHV-4157 for the treatment of ... the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that ...
(Date:5/23/2016)... ... May 23, 2016 , ... The need for blood donations in South Texas and across ... South Texas Blood & Tissue Center, blood donations are on the decline. In fact, donations ... are down 21 percent in South Texas in the last four years alone. , There ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):